CA4P via iontophoresis?
At today’s Roth webcast, OXGN’s CEO, Fred Driscoll, said the company might use iontophoresis for a local formulation of CA4P. This was more information than either Fred or CSO Dai Chaplin had revealed at OXGN’s quarterly CC last week.
Isolution et al: comments?
“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”